Developing a new medical/cosmetic device whose technology is already classified by the FDA vs. developing a device with novel technology can have different development pathways and timelines. These pathways and how the device could be classified under the FDA system of classification (e.g. class I , II, III) will be discussed during an October 11 webinar developed by the Independent Cosmetic Manufacturers and Distributors (ICMAD
The implications of being given a certain classification, as well as what you can say in marketing materials based on that classification will be highlighted. This webinar will also address the issue of approaching a claims support study for any medical device product that produces a cosmetic endpoint. We will discuss the different types of claims available and how they are supported as well as the science of study deign for these unique products.
Presenters include Dr. Robb Akridge, founder and CEO, REA Innovations and Craig Weiss, president, Consumer Product Testing Co., Inc.
To learn more, and to register, click here